Feature | April 18, 2014

SEARCH-AF Trial Shows Pharmacists Can Use Pocket ECG to Detect AFib, Stroke Risk

Heart monitor identifies asymptomatic patients with unknown atrial fibrillation at high risk of stroke

April 18, 2014 — AliveCor announced the online publication of study results of the SEARCH-AF study. The SEARCH-AF study, conducted in Australia, screened 1,000 customers over 65 years old for atrial fibrillation (AF) in 10 community pharmacies in suburban Sydney.

The AliveCor heart monitor was used to capture 30-60 second ECG (electrocardiogram) recordings and wirelessly transmit the recordings to study cardiologists. This simple method of remote ECG capture enabled study cardiologists to identify patients at risk of stroke because of unknown AF, and flag them for additional evaluation. New AF was identified in 1.5 percent of the people screened, all at high risk of stroke. Most of the people with newly discovered AF had no symptoms, and may never have sought medical advice.

This study highlights one application of mobile ECG technology that can help facilitate cost-effective preventative medical care. Additionally, the study found the incremental cost-effectiveness ratio was just over $4,000 for an increase of one quality adjusted life year (QALY) and just over $20,000 for preventing one stroke. If asymptomatic people with AF are detected in this way and given warfarin or other newer blood thinners, the risk of stroke can potentially be reduced by two thirds.

The study, “Feasibility and cost effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies,” appeared in the April 1 online issue of Thrombosis and Haemostasis and was led by Ben Freedman, M.D., professor of cardiology, Concord Hospital Department of Cardiology and Anzac Research Institute, Sydney Medical School, University of Sydney.

 “Community screening using the AliveCor heart monitor in pharmacies has shown to be both feasible and cost-effective in helping physicians identify people with AF, the most common abnormal heart rhythm, which is responsible for a third of all strokes,” said Freedman. “In many cases AF is not known before a stroke, so screening for AF and treating with effective medications could make an impact on reducing the community burden of stroke.”

“We believe these findings have great significance for health providers and should become part of routine practice as this type of screening program is a cost-effective way to identify patients with asymptomatic atrial fibrillation, a condition that can lead to potentially life threatening complications,” said Euan Thomson, president and CEO of AliveCor.

The AliveCor heart monitor is the only U.S. Food and Drug Administration (FDA) cleared mobile ECG recorder that supports both iPhone and Android smartphones. It records, displays (when prescribed or used under the care of a physician), stores and transfers single-channel ECG rhythms wirelessly, using the free AliveECG app. With secure storage in the cloud, users can access their data confidentially anytime, anywhere, and can grant access to their physicians. The heart monitor is available for purchase in the United States by health professionals and consumers.

For more information: www.alivecor.com

Related Content

iSmartweaR, smart clothing, jIndustrial Technology Research Institute, ITRI, wearable heart monitoring

An example of an iSmartweaR shirt that can monitor patient vital signs without the need for electrode wires.

News | Wearable Sensors| October 24, 2016
October 24, 2016 — Conventional smart clothing uses conductive fibers or rubber as sensing electrodes, and cardiac el
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
News | Wearable Sensors| October 13, 2016
Biotricity Inc. announced recently that it will be expanding its existing research partnership with the University of...
AirStrip One, ECG management, web client, U.S. clearance
Technology | ECG| October 11, 2016
The U.S. Food and Drug Administration (FDA) has issued 510(K) Class II clearance to a web client for the AirStrip One...
News | Cardiac Diagnostics| September 28, 2016
Increasing stomach fat – especially the “hidden fat” in your abdomen – is associated with newly identified and...
BioTelemetry, CE Mark, Holter analysis software
News | Holter Monitoring Systems| September 27, 2016
BioTelemetry Inc. announced in late August that the company has received CE mark approval of its Holter analysis...
smartphones, hospital tranfers, heart attack patients, JACC study, South Korea
News | Mobile Devices| September 23, 2016
Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for...
ACC, American College of Cardiology, Google search, heart conditions, Health Knowledge Graphs
News | Information Technology| September 23, 2016
A Google search for heart conditions will now prominently display important questions patients should ask their doctor...
Robert M. Califf, FDA commissioner, future of cardiovascular medicine, JACC column
News | Business| September 23, 2016
Technology advances coupled with increased use of social media and personal devices could offer new possibilities for...
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Results from a new study suggest that small molecules known as microRNAs may be part of the path
Overlay Init